APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peroxisome Proliferator Activated

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peroxisome Proliferator Activated Industry Growth and Trends Forecast to 2032

26 December 202596 pages

Choose your research edition.

Industry ResearchPeroxisome Proliferator Activated Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Peroxisome Proliferator Activated Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Peroxisome Proliferator Activated Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peroxisome Proliferator Activated Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Peroxisome Proliferator Activated Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Peroxisome Proliferator Activated market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peroxisome Proliferator Activated is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peroxisome Proliferator Activated is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peroxisome Proliferator Activated is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peroxisome Proliferator Activated include Chipscreen Biosciences Ltd, Connexios Life Sciences Pvt Ltd, CymaBay Therapeutics Inc, Genfit SA, Inventiva, Mitobridge Inc, Nippon Chemiphar Co Ltd, Senju Pharmaceutical Co Ltd and T3D Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peroxisome Proliferator Activated market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peroxisome Proliferator Activated market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peroxisome Proliferator Activated market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peroxisome Proliferator Activated.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peroxisome Proliferator Activated market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peroxisome Proliferator Activated Market by Company

Chipscreen Biosciences Ltd

Connexios Life Sciences Pvt Ltd

CymaBay Therapeutics Inc

Genfit SA

Inventiva

Mitobridge Inc

Nippon Chemiphar Co Ltd

Senju Pharmaceutical Co Ltd

T3D Therapeutics Inc

Peroxisome Proliferator Activated Segment by Type

CNX-013B2

CS-038

HPP-593

MA-0204

MTB-2

Others

Peroxisome Proliferator Activated Segment by Application

Obesity

Bone Disorders

Osteoporosis

Colitis

Others

Peroxisome Proliferator Activated Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peroxisome Proliferator Activated market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peroxisome Proliferator Activated and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peroxisome Proliferator Activated.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peroxisome Proliferator Activated manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peroxisome Proliferator Activated in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CNX-013B2 Table 2. Major Company of CS-038 Table 3. Major Company of HPP-593 Table 4. Major Company of MA-0204 Table 5. Major Company of MTB-2 Table 6. Major Company of Others Table 7. Global Peroxisome Proliferator Activated Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Peroxisome Proliferator Activated Sales by Type (2021-2026) & (W Units) Table 9. Global Peroxisome Proliferator Activated Sales Market Share in Volume by Type (2021-2026) Table 10. Global Peroxisome Proliferator Activated Sales by Type (2021-2026) & (US$ Million) Table 11. Global Peroxisome Proliferator Activated Sales Market Share in Value by Type (2021-2026) Table 12. Global Peroxisome Proliferator Activated Price by Type (2021-2026) & (US$/Unit) Table 13. Global Peroxisome Proliferator Activated Sales by Type (2027-2032) & (W Units) Table 14. Global Peroxisome Proliferator Activated Sales Market Share in Volume by Type (2027-2032) Table 15. Global Peroxisome Proliferator Activated Sales by Type (2027-2032) & (US$ Million) Table 16. Global Peroxisome Proliferator Activated Sales Market Share in Value by Type (2027-2032) Table 17. Global Peroxisome Proliferator Activated Price by Type (2027-2032) & (US$/Unit) Table 18. North America Peroxisome Proliferator Activated Sales by Type (2021-2026) & (W Units) Table 19. North America Peroxisome Proliferator Activated Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Peroxisome Proliferator Activated Sales by Type (2021-2026) & (W Units) Table 21. Europe Peroxisome Proliferator Activated Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Peroxisome Proliferator Activated Sales by Type (2021-2026) & (W Units) Table 23. Asia-Pacific Peroxisome Proliferator Activated Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Peroxisome Proliferator Activated Sales by Type (2021-2026) & (W Units) Table 25. Latin America Peroxisome Proliferator Activated Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Peroxisome Proliferator Activated Sales by Type (2021-2026) & (W Units) Table 27. Middle East and Africa Peroxisome Proliferator Activated Sales by Type (2021-2026) & (US$ Million) Table 28. Peroxisome Proliferator Activated Industry Trends Table 29. Peroxisome Proliferator Activated Industry Drivers Table 30. Peroxisome Proliferator Activated Industry Opportunities and Challenges Table 31. Peroxisome Proliferator Activated Industry Restraints Table 32. Global Peroxisome Proliferator Activated Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Peroxisome Proliferator Activated Revenue Market Share by Company (2021-2026) Table 34. Global Peroxisome Proliferator Activated Sales by Company (2021-2026) & (W Units) Table 35. Global Peroxisome Proliferator Activated Sales Share by Company (2021-2026) Table 36. Global Peroxisome Proliferator Activated Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Peroxisome Proliferator Activated Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Peroxisome Proliferator Activated Major Company Production Sites and Headquarters Table 39. Global Peroxisome Proliferator Activated Company, Product Type & Application Table 40. Global Peroxisome Proliferator Activated Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Peroxisome Proliferator Activated by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Peroxisome Proliferator Activated Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Peroxisome Proliferator Activated Sales by Region (2021-2026) & (W Units) Table 45. Global Peroxisome Proliferator Activated Sales Market Share in Volume by Region (2021-2026) Table 46. Global Peroxisome Proliferator Activated Sales by Region (2021-2026) & (US$ Million) Table 47. Global Peroxisome Proliferator Activated Sales Market Share in Value by Region (2021-2026) Table 48. Global Peroxisome Proliferator Activated Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Peroxisome Proliferator Activated Sales by Region (2027-2032) & (W Units) Table 50. Global Peroxisome Proliferator Activated Sales Market Share in Volume by Region (2027-2032) Table 51. Global Peroxisome Proliferator Activated Sales by Region (2027-2032) & (US$ Million) Table 52. Global Peroxisome Proliferator Activated Sales Market Share in Value by Region (2027-2032) Table 53. Global Peroxisome Proliferator Activated Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Peroxisome Proliferator Activated Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Peroxisome Proliferator Activated Sales by Application (2021-2026) & (W Units) Table 56. Global Peroxisome Proliferator Activated Sales Market Share in Volume by Application (2021-2026) Table 57. Global Peroxisome Proliferator Activated Sales by Application (2021-2026) & (US$ Million) Table 58. Global Peroxisome Proliferator Activated Sales Market Share in Value by Application (2021-2026) Table 59. Global Peroxisome Proliferator Activated Price by Application (2021-2026) & (US$/Unit) Table 60. Global Peroxisome Proliferator Activated Sales by Application (2027-2032) & (W Units) Table 61. Global Peroxisome Proliferator Activated Sales Market Share in Volume by Application (2027-2032) Table 62. Global Peroxisome Proliferator Activated Sales by Application (2027-2032) & (US$ Million) Table 63. Global Peroxisome Proliferator Activated Sales Market Share in Value by Application (2027-2032) Table 64. Global Peroxisome Proliferator Activated Price by Application (2027-2032) & (US$/Unit) Table 65. North America Peroxisome Proliferator Activated Sales by Application (2021-2026) & (W Units) Table 66. North America Peroxisome Proliferator Activated Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Peroxisome Proliferator Activated Sales by Application (2021-2026) & (W Units) Table 68. Europe Peroxisome Proliferator Activated Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Peroxisome Proliferator Activated Sales by Application (2021-2026) & (W Units) Table 70. Asia-Pacific Peroxisome Proliferator Activated Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Peroxisome Proliferator Activated Sales by Application (2021-2026) & (W Units) Table 72. Latin America Peroxisome Proliferator Activated Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Peroxisome Proliferator Activated Sales by Application (2021-2026) & (W Units) Table 74. Middle East and Africa Peroxisome Proliferator Activated Sales by Application (2021-2026) & (US$ Million) Table 75. Chipscreen Biosciences Ltd Company Information Table 76. Chipscreen Biosciences Ltd Business Overview Table 77. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Product Portfolio Table 79. Chipscreen Biosciences Ltd Recent Development Table 80. Connexios Life Sciences Pvt Ltd Company Information Table 81. Connexios Life Sciences Pvt Ltd Business Overview Table 82. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Product Portfolio Table 84. Connexios Life Sciences Pvt Ltd Recent Development Table 85. CymaBay Therapeutics Inc Company Information Table 86. CymaBay Therapeutics Inc Business Overview Table 87. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Product Portfolio Table 89. CymaBay Therapeutics Inc Recent Development Table 90. Genfit SA Company Information Table 91. Genfit SA Business Overview Table 92. Genfit SA Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Genfit SA Peroxisome Proliferator Activated Product Portfolio Table 94. Genfit SA Recent Development Table 95. Inventiva Company Information Table 96. Inventiva Business Overview Table 97. Inventiva Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Inventiva Peroxisome Proliferator Activated Product Portfolio Table 99. Inventiva Recent Development Table 100. Mitobridge Inc Company Information Table 101. Mitobridge Inc Business Overview Table 102. Mitobridge Inc Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Mitobridge Inc Peroxisome Proliferator Activated Product Portfolio Table 104. Mitobridge Inc Recent Development Table 105. Nippon Chemiphar Co Ltd Company Information Table 106. Nippon Chemiphar Co Ltd Business Overview Table 107. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Product Portfolio Table 109. Nippon Chemiphar Co Ltd Recent Development Table 110. Senju Pharmaceutical Co Ltd Company Information Table 111. Senju Pharmaceutical Co Ltd Business Overview Table 112. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Product Portfolio Table 114. Senju Pharmaceutical Co Ltd Recent Development Table 115. T3D Therapeutics Inc Company Information Table 116. T3D Therapeutics Inc Business Overview Table 117. T3D Therapeutics Inc Peroxisome Proliferator Activated Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. T3D Therapeutics Inc Peroxisome Proliferator Activated Product Portfolio Table 119. T3D Therapeutics Inc Recent Development Table 120. North America Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 121. North America Peroxisome Proliferator Activated Sales by Country (2021-2026) & (W Units) Table 122. North America Peroxisome Proliferator Activated Sales Market Share by Country (2021-2026) Table 123. North America Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032) & (W Units) Table 124. North America Peroxisome Proliferator Activated Sales Market Share Forecast by Country (2027-2032) Table 125. North America Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. North America Peroxisome Proliferator Activated Market Size by Country (2021-2026) & (US$ Million) Table 127. North America Peroxisome Proliferator Activated Market Share by Country (2021-2026) Table 128. North America Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. North America Peroxisome Proliferator Activated Market Share Forecast by Country (2027-2032) Table 130. Europe Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 131. Europe Peroxisome Proliferator Activated Sales by Country (2021-2026) & (W Units) Table 132. Europe Peroxisome Proliferator Activated Sales Market Share by Country (2021-2026) Table 133. Europe Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032) & (W Units) Table 134. Europe Peroxisome Proliferator Activated Sales Market Share Forecast by Country (2027-2032) Table 135. Europe Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Europe Peroxisome Proliferator Activated Market Size by Country (2021-2026) & (US$ Million) Table 137. Europe Peroxisome Proliferator Activated Market Share by Country (2021-2026) Table 138. Europe Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Europe Peroxisome Proliferator Activated Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Peroxisome Proliferator Activated Sales by Country (2021-2026) & (W Units) Table 142. Asia-Pacific Peroxisome Proliferator Activated Sales Market Share by Country (2021-2026) Table 143. Asia-Pacific Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032) & (W Units) Table 144. Asia-Pacific Peroxisome Proliferator Activated Sales Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Peroxisome Proliferator Activated Market Size by Country (2021-2026) & (US$ Million) Table 147. Asia-Pacific Peroxisome Proliferator Activated Market Share by Country (2021-2026) Table 148. Asia-Pacific Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Asia-Pacific Peroxisome Proliferator Activated Market Share Forecast by Country (2027-2032) Table 150. Latin America Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 151. Latin America Peroxisome Proliferator Activated Sales by Country (2021-2026) & (W Units) Table 152. Latin America Peroxisome Proliferator Activated Sales Market Share by Country (2021-2026) Table 153. Latin America Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032) & (W Units) Table 154. Latin America Peroxisome Proliferator Activated Sales Market Share Forecast by Country (2027-2032) Table 155. Latin America Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Latin America Peroxisome Proliferator Activated Market Size by Country (2021-2026) & (US$ Million) Table 157. Latin America Peroxisome Proliferator Activated Market Share by Country (2021-2026) Table 158. Latin America Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Latin America Peroxisome Proliferator Activated Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Peroxisome Proliferator Activated Sales by Country (2021-2026) & (W Units) Table 162. Middle East and Africa Peroxisome Proliferator Activated Sales Market Share by Country (2021-2026) Table 163. Middle East and Africa Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032) & (W Units) Table 164. Middle East and Africa Peroxisome Proliferator Activated Sales Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Peroxisome Proliferator Activated Market Size by Country (2021-2026) & (US$ Million) Table 167. Middle East and Africa Peroxisome Proliferator Activated Market Share by Country (2021-2026) Table 168. Middle East and Africa Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Middle East and Africa Peroxisome Proliferator Activated Market Share Forecast by Country (2027-2032) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Peroxisome Proliferator Activated Distributors List Table 173. Peroxisome Proliferator Activated Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Peroxisome Proliferator Activated Image Figure 2. Global Peroxisome Proliferator Activated Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peroxisome Proliferator Activated Market Size (2021-2032) & (US$ Million) Figure 4. Global Peroxisome Proliferator Activated Sales (2021-2032) & (W Units) Figure 5. CNX-013B2 Image Figure 6. Global CNX-013B2 Sales YoY Growth (2021-2032) & (W Units) Figure 7. CS-038 Image Figure 8. Global CS-038 Sales YoY Growth (2021-2032) & (W Units) Figure 9. HPP-593 Image Figure 10. Global HPP-593 Sales YoY Growth (2021-2032) & (W Units) Figure 11. MA-0204 Image Figure 12. Global MA-0204 Sales YoY Growth (2021-2032) & (W Units) Figure 13. MTB-2 Image Figure 14. Global MTB-2 Sales YoY Growth (2021-2032) & (W Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 17. Global Peroxisome Proliferator Activated Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Peroxisome Proliferator Activated Market Share by Type 2025 VS 2032 Figure 19. North America Peroxisome Proliferator Activated Sales Market Share in Volume by Type in 2025 Figure 20. North America Peroxisome Proliferator Activated Sales Market Share in Value by Type in 2025 Figure 21. Europe Peroxisome Proliferator Activated Sales Market Share in Volume by Type in 2025 Figure 22. Europe Peroxisome Proliferator Activated Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Peroxisome Proliferator Activated Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Peroxisome Proliferator Activated Sales Market Share in Value by Type in 2025 Figure 25. Latin America Peroxisome Proliferator Activated Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Peroxisome Proliferator Activated Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Peroxisome Proliferator Activated Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Peroxisome Proliferator Activated Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Peroxisome Proliferator Activated Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Obesity Image Figure 32. Global Obesity Sales YoY Growth (2021-2032) & (W Units) Figure 33. Bone Disorders Image Figure 34. Global Bone Disorders Sales YoY Growth (2021-2032) & (W Units) Figure 35. Osteoporosis Image Figure 36. Global Osteoporosis Sales YoY Growth (2021-2032) & (W Units) Figure 37. Colitis Image Figure 38. Global Colitis Sales YoY Growth (2021-2032) & (W Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 41. Global Peroxisome Proliferator Activated Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Peroxisome Proliferator Activated Market Share by Application 2025 VS 2032 Figure 43. North America Peroxisome Proliferator Activated Sales Market Share in Volume by Application in 2025 Figure 44. North America Peroxisome Proliferator Activated Sales Market Share in Value by Application in 2025 Figure 45. Europe Peroxisome Proliferator Activated Sales Market Share in Volume by Application in 2025 Figure 46. Europe Peroxisome Proliferator Activated Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Peroxisome Proliferator Activated Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Peroxisome Proliferator Activated Sales Market Share in Value by Application in 2025 Figure 49. Latin America Peroxisome Proliferator Activated Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Peroxisome Proliferator Activated Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Peroxisome Proliferator Activated Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Peroxisome Proliferator Activated Sales Market Share in Value by Application in 2025 Figure 53. North America Peroxisome Proliferator Activated Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. North America Peroxisome Proliferator Activated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Peroxisome Proliferator Activated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Peroxisome Proliferator Activated Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Peroxisome Proliferator Activated Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Europe Peroxisome Proliferator Activated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Peroxisome Proliferator Activated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Peroxisome Proliferator Activated Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Peroxisome Proliferator Activated Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Asia-Pacific Peroxisome Proliferator Activated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Peroxisome Proliferator Activated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Peroxisome Proliferator Activated Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Peroxisome Proliferator Activated Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Latin America Peroxisome Proliferator Activated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Peroxisome Proliferator Activated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Peroxisome Proliferator Activated Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Peroxisome Proliferator Activated Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 70. Middle East and Africa Peroxisome Proliferator Activated Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Peroxisome Proliferator Activated Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Peroxisome Proliferator Activated Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Peroxisome Proliferator Activated Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Peroxisome Proliferator Activated Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • CNX-013B2
  • CS-038
  • HPP-593
  • MA-0204
  • MTB-2
  • Others
Applications
  • Obesity
  • Bone Disorders
  • Osteoporosis
  • Colitis
  • Others
Companies covered
  • Chipscreen Biosciences Ltd
  • Connexios Life Sciences Pvt Ltd
  • CymaBay Therapeutics Inc
  • Genfit SA
  • Inventiva
  • Mitobridge Inc
  • Nippon Chemiphar Co Ltd
  • Senju Pharmaceutical Co Ltd
  • T3D Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peroxisome Proliferator Activated Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peroxisome Proliferator Activated Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peroxisome Proliferator Activated Market by Type
  6. 1.3.1 CNX-013B2
  7. 1.3.2 CS-038
  8. 1.3.3 HPP-593
  9. 1.3.4 MA-0204
  10. 1.3.5 MTB-2
  11. 1.3.6 Others
  12. 1.4 Global Peroxisome Proliferator Activated Market Size by Type
  13. 1.4.1 Global Peroxisome Proliferator Activated Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Peroxisome Proliferator Activated Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Peroxisome Proliferator Activated Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Peroxisome Proliferator Activated Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Peroxisome Proliferator Activated Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Peroxisome Proliferator Activated Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Peroxisome Proliferator Activated Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Peroxisome Proliferator Activated Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peroxisome Proliferator Activated Industry Trends
  2. 2.2 Peroxisome Proliferator Activated Industry Drivers
  3. 2.3 Peroxisome Proliferator Activated Industry Opportunities and Challenges
  4. 2.4 Peroxisome Proliferator Activated Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peroxisome Proliferator Activated Revenue (2021-2026)
  2. 3.2 Global Top Players by Peroxisome Proliferator Activated Sales (2021-2026)
  3. 3.3 Global Top Players by Peroxisome Proliferator Activated Price (2021-2026)
  4. 3.4 Global Peroxisome Proliferator Activated Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peroxisome Proliferator Activated Major Company Production Sites & Headquarters
  6. 3.6 Global Peroxisome Proliferator Activated Company, Product Type & Application
  7. 3.7 Global Peroxisome Proliferator Activated Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peroxisome Proliferator Activated Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peroxisome Proliferator Activated Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peroxisome Proliferator Activated Tier 1, Tier 2, and Tier 3
4 Peroxisome Proliferator Activated Regional Status and Outlook
  1. 4.1 Global Peroxisome Proliferator Activated Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peroxisome Proliferator Activated Historic Market Size by Region
  3. 4.2.1 Global Peroxisome Proliferator Activated Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peroxisome Proliferator Activated Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peroxisome Proliferator Activated Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peroxisome Proliferator Activated Forecasted Market Size by Region
  7. 4.3.1 Global Peroxisome Proliferator Activated Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peroxisome Proliferator Activated Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peroxisome Proliferator Activated Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peroxisome Proliferator Activated by Application
  1. 5.1 Peroxisome Proliferator Activated Market by Application
  2. 5.1.1 Obesity
  3. 5.1.2 Bone Disorders
  4. 5.1.3 Osteoporosis
  5. 5.1.4 Colitis
  6. 5.1.5 Others
  7. 5.2 Global Peroxisome Proliferator Activated Market Size by Application
  8. 5.2.1 Global Peroxisome Proliferator Activated Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Peroxisome Proliferator Activated Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Peroxisome Proliferator Activated Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Peroxisome Proliferator Activated Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Peroxisome Proliferator Activated Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Peroxisome Proliferator Activated Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Peroxisome Proliferator Activated Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Peroxisome Proliferator Activated Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chipscreen Biosciences Ltd
  2. 6.1.1 Chipscreen Biosciences Ltd Company Information
  3. 6.1.2 Chipscreen Biosciences Ltd Business Overview
  4. 6.1.3 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Product Portfolio
  6. 6.1.5 Chipscreen Biosciences Ltd Recent Developments
  7. 6.2 Connexios Life Sciences Pvt Ltd
  8. 6.2.1 Connexios Life Sciences Pvt Ltd Company Information
  9. 6.2.2 Connexios Life Sciences Pvt Ltd Business Overview
  10. 6.2.3 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Product Portfolio
  12. 6.2.5 Connexios Life Sciences Pvt Ltd Recent Developments
  13. 6.3 CymaBay Therapeutics Inc
  14. 6.3.1 CymaBay Therapeutics Inc Company Information
  15. 6.3.2 CymaBay Therapeutics Inc Business Overview
  16. 6.3.3 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Product Portfolio
  18. 6.3.5 CymaBay Therapeutics Inc Recent Developments
  19. 6.4 Genfit SA
  20. 6.4.1 Genfit SA Company Information
  21. 6.4.2 Genfit SA Business Overview
  22. 6.4.3 Genfit SA Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genfit SA Peroxisome Proliferator Activated Product Portfolio
  24. 6.4.5 Genfit SA Recent Developments
  25. 6.5 Inventiva
  26. 6.5.1 Inventiva Company Information
  27. 6.5.2 Inventiva Business Overview
  28. 6.5.3 Inventiva Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Inventiva Peroxisome Proliferator Activated Product Portfolio
  30. 6.5.5 Inventiva Recent Developments
  31. 6.6 Mitobridge Inc
  32. 6.6.1 Mitobridge Inc Company Information
  33. 6.6.2 Mitobridge Inc Business Overview
  34. 6.6.3 Mitobridge Inc Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mitobridge Inc Peroxisome Proliferator Activated Product Portfolio
  36. 6.6.5 Mitobridge Inc Recent Developments
  37. 6.7 Nippon Chemiphar Co Ltd
  38. 6.7.1 Nippon Chemiphar Co Ltd Company Information
  39. 6.7.2 Nippon Chemiphar Co Ltd Business Overview
  40. 6.7.3 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Product Portfolio
  42. 6.7.5 Nippon Chemiphar Co Ltd Recent Developments
  43. 6.8 Senju Pharmaceutical Co Ltd
  44. 6.8.1 Senju Pharmaceutical Co Ltd Company Information
  45. 6.8.2 Senju Pharmaceutical Co Ltd Business Overview
  46. 6.8.3 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Product Portfolio
  48. 6.8.5 Senju Pharmaceutical Co Ltd Recent Developments
  49. 6.9 T3D Therapeutics Inc
  50. 6.9.1 T3D Therapeutics Inc Company Information
  51. 6.9.2 T3D Therapeutics Inc Business Overview
  52. 6.9.3 T3D Therapeutics Inc Peroxisome Proliferator Activated Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 T3D Therapeutics Inc Peroxisome Proliferator Activated Product Portfolio
  54. 6.9.5 T3D Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Peroxisome Proliferator Activated Sales by Country
  2. 7.1.1 North America Peroxisome Proliferator Activated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peroxisome Proliferator Activated Sales by Country (2021-2026)
  4. 7.1.3 North America Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peroxisome Proliferator Activated Market Size by Country
  6. 7.2.1 North America Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peroxisome Proliferator Activated Market Size by Country (2021-2026)
  8. 7.2.3 North America Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peroxisome Proliferator Activated Sales by Country
  2. 8.1.1 Europe Peroxisome Proliferator Activated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peroxisome Proliferator Activated Sales by Country (2021-2026)
  4. 8.1.3 Europe Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peroxisome Proliferator Activated Market Size by Country
  6. 8.2.1 Europe Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peroxisome Proliferator Activated Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peroxisome Proliferator Activated Sales by Country
  2. 9.1.1 Asia-Pacific Peroxisome Proliferator Activated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peroxisome Proliferator Activated Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peroxisome Proliferator Activated Market Size by Country
  6. 9.2.1 Asia-Pacific Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peroxisome Proliferator Activated Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peroxisome Proliferator Activated Sales by Country
  2. 10.1.1 South America Peroxisome Proliferator Activated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peroxisome Proliferator Activated Sales by Country (2021-2026)
  4. 10.1.3 South America Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peroxisome Proliferator Activated Market Size by Country
  6. 10.2.1 South America Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peroxisome Proliferator Activated Market Size by Country (2021-2026)
  8. 10.2.3 South America Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peroxisome Proliferator Activated Sales by Country
  2. 11.1.1 Middle East and Africa Peroxisome Proliferator Activated Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peroxisome Proliferator Activated Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peroxisome Proliferator Activated Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peroxisome Proliferator Activated Market Size by Country
  6. 11.2.1 Middle East and Africa Peroxisome Proliferator Activated Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peroxisome Proliferator Activated Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peroxisome Proliferator Activated Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peroxisome Proliferator Activated Value Chain Analysis
  2. 12.1.1 Peroxisome Proliferator Activated Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peroxisome Proliferator Activated Production Mode & Process
  7. 12.2 Peroxisome Proliferator Activated Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peroxisome Proliferator Activated Distributors
  10. 12.2.3 Peroxisome Proliferator Activated Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst